Nektar Therapeutics
(NASDAQ) NKTR
Nektar Therapeutics Financials at a Glance
Market Cap
$1.97B
Revenue (TTM)
$55.23M
Net Income (TTM)
$164.08M
EPS (TTM)
$-10.22
P/E Ratio
-6.72
Dividend
$0.00
Beta (Volatility)
1.72 (High)
Dividend
$0.00
Beta (Volatility)
1.72 (High)
Price
$68.52
Volume
35,953
Open
$71.43
Price
$68.52
Volume
35,953
Open
$71.43
Previous Close
$68.52
Daily Range
$67.83 - $71.50
52-Week Range
$6.48 - $77.97
Dividend
$0.00
Beta (Volatility)
1.72 (High)
Price
$68.52
Volume
35,953
Open
$71.43
Previous Close
$68.52
Daily Range
$67.83 - $71.50
52-Week Range
$6.48 - $77.97
NKTR News
NKTR: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Nektar Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
63
CEO
Howard W. Robin
Website
www.nektar.comHeadquarters
San Francisco, CA 94158, US
NKTR Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-2%
Net Income Margin
-3%
Return on Equity
-218%
Return on Capital
-58%
Return on Assets
-59%
Earnings Yield
-14.88%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.97B
Shares Outstanding
28.69M
Volume
35.95K
Short Interest
0.00%
Avg. Volume
1.09M
Financials (TTM)
Gross Profit
$55.23M
Operating Income
$130.77M
EBITDA
$129.74M
Operating Cash Flow
$208.51M
Capital Expenditure
$171.00K
Free Cash Flow
$208.68M
Cash & ST Invst.
$245.75M
Total Debt
$148.91M
Nektar Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$21.81M
-25.3%
Gross Profit
$21.81M
+2.9%
Gross Margin
100.00%
N/A
Market Cap
$1.97B
N/A
Market Cap/Employee
$32.29M
N/A
Employees
61
N/A
Net Income
$36.08M
-596.9%
EBITDA
$18.90M
-208.1%
Quarterly Fundamentals
Net Cash
$96.84M
-36.6%
Accounts Receivable
$1.78M
+10.6%
Inventory
$0.00
N/A
Long Term Debt
$128.41M
+55.3%
Short Term Debt
$20.50M
+3.2%
Return on Assets
-58.51%
N/A
Return on Invested Capital
-57.91%
N/A
Free Cash Flow
$64.98M
-39.3%
Operating Cash Flow
$64.96M
-40.6%